Autophagy inhibitor LRPPRC suppresses mitophagy through interaction with mitophagy initiator Parkin

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Zou, Jing ^a,b   Yue, Fei ^a   Li, Wenjiao ^a   Song, Kun ^a   Jiang, Xianhan ^a   Yi, Jinglin ^b   Liu, Leyuan ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NANCHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY PROTEIN 12; AUTOPHAGY PROTEIN 5; MICROTUBULE ASSOCIATED PROTEIN; PARKIN; PROTEIN BCL 2; PROTEIN LRPPRC; UBIQUITINATED PROTEIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BCL2 PROTEIN, HUMAN; BECN1 PROTEIN, HUMAN; LRPPRC PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CARCINOGENESIS; CELL STRESS; CONTROLLED STUDY; MEMBRANE RUPTURE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MITOPHAGY; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TRANSPORT; TUMOR GROWTH; UBIQUITINATION; HELA CELL LINE; HUMAN; METABOLISM; PHAGOSOME; PHYSIOLOGY;

APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CARCINOGENESIS; HELA CELLS; HUMANS; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; NEOPLASM PROTEINS; PHAGOSOMES; PROTO-ONCOGENE PROTEINS C-BCL-2; UBIQUITIN-PROTEIN LIGASES;

EID: 84899533447     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094903     Document Type: Article

References (48)

1. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, et al. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728.
2. Tanida I, Ueno T, Kominami E (2004) LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 36: 2503-2518. (Pubitemid 39119762)
3. Mizushima N, Levine B, Cuervo AM, Klionsky DJ (2008) Autophagy fights disease through cellular self-digestion. Nature 451: 1069-1075. (Pubitemid 351317450)
4. Liu L, Xie R, Nguyen S, Ye M, McKeehan WL (2009) Robust autophagy/mitophagy persists during mitosis. Cell Cycle 8: 1616-1620.
5. Terman A, Gustafsson B, Brunk UT (2006) The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. Chem Biol Interact 163: 29-37. (Pubitemid 44572212)
6. Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, et al. (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12: 119-131.
7. Narendra D, Kane LA, Hauser DN, Fearnley IM, Youle RJ (2010) p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. Autophagy 6: 1090-1106.
8. White E, DiPaola RS (2009) The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 15: 5308-5316.
9. Liu L, Amy V, Liu G, McKeehan WL (2002) Novel complex integrating mitochondria and the microtubular cytoskeleton with chromosome remodeling and tumor suppressor RASSF1 deduced by in silico homology analysis, interaction cloning in yeast, and colocalization in cultured cells. In Vitro Cell Dev Biol Anim 38: 582-594. (Pubitemid 36666244)
10. Liu L, McKeehan WL (2002) Sequence analysis of LRPPRC and its SEC1 domain interaction partners suggest roles in cytoskeletal organization, vesicular trafficking, nucleocytosolic shuttling and chromosome activity. Genomics 79: 124-136. (Pubitemid 34112074)
11. Liu L, Vo A, Liu G, McKeehan WL (2005) Putative tumor suppressor RASSF1 interactive protein and cell death inducer C19ORF5 is a DNA binding protein. Biochem Biophys Res Commun 332: 670-676. (Pubitemid 40745167)
12. Mootha VK, Lepage P, Miller K, Bunkenborg J, Reich M, et al. (2003) Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci USA 100: 605-610. (Pubitemid 36126099)
13. Vandin F, Clay P, Upfal E, Raphael BJ (2012.) Discovery of Mutated Subnetworks Associated with Clinical Data in Cancer. Pac Symp Biocomput 2012: 55-66.
14. Kayaba H, Hirokawa M, Watanabe A, Saitoh N, Changhao C, et al. (2000) Serum markers of graft-versus-host disease after bone marrow transplantation. J Allergy Clin Immunol 106: S40-44. (Pubitemid 30482833)
15. Schoenfeld TA, McKerracher L, Obar R, Vallee RB (1989) MAP 1A and MAP 1B are structurally related microtubule associated proteins with distinct developmental patterns in the CNS. J Neurosci 9: 1712-1730. (Pubitemid 19146267)
16. Xie R, Nguyen S, McKeehan K, Wang F, McKeehan WL, et al. (2011) Microtubule-associated protein 1S (MAP1S) bridges autophagic components with microtubules and mitochondria to affect autophagosomal biogenesis and degradation. J Biol Chem 286: 10367-10377.
17. Xie R, Wang F, McKeehan WL, Liu L (2011) Autophagy enhanced by microtubule- and mitochondrion-associated MAP1S suppresses genome instability and hepatocarcinogenesis. Cancer Res 71: 7537-7546.
18. Liu L, McKeehan WL, Wang F, Xie R (2012) MAP1S enhances autophagy to suppress tumorigenesis. Autophagy 8: 278-280.
19. Jiang X, Li X, Huang H, Jiang F, Lin Z, et al. (2014) Elevated levels of mitochondrion-associated autophagy inhibitor LRPPRC are associated with poor prognosis of human patients with prostate cancer. Cancer 2014 Jan 3. doi: 10.1002/cncr.28551
20. Li X, Lv L, Zheng J, Zhou J, Liu B, et al. (2014) The significance of LRPPRC overexpression in gastric cancer. Med Oncol 31: 818.
21. Zou J, Yue F, Jiang X, Li W, Yi J, et al. (2013) Mitochondrion-associated protein LRPPRC suppresses the initiation of basal levels of autophagy via enhancing Bcl-2 stability. Biochem J 454: 447-457.
22. Mili S, Pinol-Roma S (2003) LRP130, a pentatricopeptide motif protein with a noncanonical RNA-binding domain, is bound in vivo to mitochondrial and nuclear RNAs. Mol Cell Biol 23: 4972-4982. (Pubitemid 36793342)
23. Davison EJ, Pennington K, Hung CC, Peng J, Rafiq R, et al. (2009) Proteomic analysis of increased Parkin expression and its interactants provides evidence for a role in modulation of mitochondrial function. Proteomics 9: 4284-4297.
24. Zanon A, Rakovic A, Blankenburg H, Doncheva NT, Schwienbacher C, et al. (2013) Profiling of Parkin-binding partners using tandem affinity purification. PLoS One 8: e78648.
25. Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y (2004) In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 15: 1101-1111. (Pubitemid 38316219)
26. Narendra D, Tanaka A, Suen DF, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183: 795-803.
27. Liu L, Xie R, Yang C, McKeehan WL (2009) Dual function microtubule- and mitochondria-associated proteins mediate mitotic cell death. Cell Oncol 31: 393-405.
28. Liu L, Vo A, McKeehan WL (2005) Specificity of the methylation-suppressed A isoform of candidate tumor suppressor RASSF1 for microtubule hyperstabilization is determined by cell death inducer C19ORF5. Cancer Res 65: 1830-1838. (Pubitemid 40478611)
29. Youle RJ, Narendra DP (2011) Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12: 9-14.
30. Galindo MF, Solesio ME, Atienzar-Aroca S, Zamora MJ, Jordan Bueso J (2012) Mitochondrial dynamics and mitophagy in the 6-hydroxydopamine preclinical model of Parkinson's disease. Parkinsons Dis 2012: 131058.
31. Rakovic A, Grunewald A, Voges L, Hofmann S, Orolicki S, et al. (2011) PINK1-Interacting Proteins: Proteomic Analysis of Overexpressed PINK1. Parkinsons Dis 2011: 153979.
32. Yoshii SR, Kishi C, Ishihara N, Mizushima N (2011) Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J Biol Chem 286: 19630-19640.
33. Chen D, Gao F, Li B, Wang H, Xu Y, et al. (2010) Parkin mono-ubiquitinates Bcl-2 and regulates autophagy. J Biol Chem 285: 38214-38223.
34. Narendra D, Tanaka A, Suen DF, Youle RJ (2009) Parkin-induced mitophagy in the pathogenesis of Parkinson disease. Autophagy 5: 706-708.
35. Glauser L, Sonnay S, Stafa K, Moore DJ (2011) Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1. J Neurochem 118: 636-645.
36. Wang H, Song P, Du L, Tian W, Yue W, et al. (2011) Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson disease. J Biol Chem 286: 11649-11658.
37. Sarraf SA, Raman M, Guarani-Pereira V, Sowa ME, Huttlin EL, et al. (2013) Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 496: 372-376.
38. Henchcliffe C, Beal MF (2008) Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 4: 600-609.
39. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, et al. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301-1306.
40. Plun-Favreau H, Lewis PA, Hardy J, Martins LM, Wood NW (2010) Cancer and neurodegeneration: between the devil and the deep blue sea. PLoS Genet 6: e1001257.
41. Desagher S, Martinou JC (2000) Mitochondria as the central control point of apoptosis. Trends Cell Biol 10: 369-377. (Pubitemid 30612469)
42. De Vos K, Goossens V, Boone E, Vercammen D, Vancompernolle K, et al. (1998) The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region. J Biol Chem 273: 9673-9680. (Pubitemid 28183057)
43. Boya P, Gonzalez-Polo RA, Casares N, Perfettini JL, Dessen P, et al. (2005) Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25: 1025-1040. (Pubitemid 40165810)
44. Lessene G, Czabotar PE, Colman PM (2008) BCL-2 family antagonists for cancer therapy. Nat Rev Drug Discov 7: 989-1000.
45. Catz SD, Johnson JL (2003) BCL-2 in prostate cancer: a minireview. Apoptosis 8: 29-37. (Pubitemid 36133135)
46. Mathupala SP, Ko YH, Pedersen PL (2010) The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies. Biochim Biophys Acta 1797: 1225-1230.
47. Parr RL, Mills J, Harbottle A, Creed JM, Crewdson G, et al. (2013) Mitochondria, prostate cancer, and biopsy sampling error. Discov Med 15: 213-220.
48. Herrmann PC, Gillespie JW, Charboneau L, Bichsel VE, Paweletz CP, et al. (2003) Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer. Proteomics 3: 1801-1810. (Pubitemid 37129826)